INVITATION DELPHI STUDY: PHYSICAL THERAPY IN PEOPLE WITH PSORIATIC ARTHRITIS
Beste reumatoloog, huisarts en kinesitherapeut,
News
Patient Partners Program needs your help
Did you know that there is no student in medicine in Flanders that graduates without getting a Patient Partners course?
This has been the case for many years, but now we struggle to keep this promise: we can not find enough patients with RA or SpA who are willing to become a Patient Partner. Put the affiche (attached) in your waiting room and distribute the leaflet amongst your patients. Contact jorien@r-euma.be for ordering (free) printed versions.
Technische problemen infliximab opgelost - Problèmes techniques infliximab résolus
RIZIV verontschuldigt zich voor de langdurig aanslepende problemen met de aanvragen voor vergoeding in bepaalde paragrafen van infliximab.
Graag wensen wij u te laten weten dat de technische problemen met betrekking tot de volgende paragrafen sinds deze ochtend opgelost zijn na overleg met de verschillende verzekeringsinstellingen:
WE CARE platform
Online WEekly Complex And Rare diseases Exchange platform.
RESOLVED - Stock problems Orencia 125mg, SC
Update 20/06/2022: BMS confirmed that also the SC Clickjet pen of Orencia is again available.
Evenity® (Romosozumab) available as of December 1st, 2021
In Europe, Evenity® is registered for the treatment of severe osteoporosis in postmenopausal women at high risk of bone fractures.
Change of paragraph for Rinvoq
The refund paragraph for Rinvoq® (upadacitinib) in rheumatoid arthritis (RA) will change
RoActemra stock issue
The pharmaceutical company Roche has announced possible stock issues concerning the medicine RoActemra (IV and SC).
